NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
4.910
+0.060 (1.24%)
Feb 13, 2026, 4:00 PM EST - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $52.31 million as of February 13, 2026. Its market cap has increased by 176.51% in one year.
Market Cap
52.31M
Enterprise Value
48.43M
1-Year Change
176.51%
Ranking
Category
Stock Price
$4.91
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $52.31M, an increase of 184.70%. That is a compound annual growth rate of 51.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 52.31M | 8.15% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InflaRx | 58.43M |
| Grace Therapeutics | 56.48M |
| BeyondSpring | 56.34M |
| Tevogen Bio Holdings | 55.34M |
| Radiopharm Theranostics | 55.31M |
| Kazia Therapeutics | 55.24M |
| Metagenomi Therapeutics | 55.19M |
| TScan Therapeutics | 54.88M |